Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $1,840,216 | reported | |
| FY 2020 | 2020-12-31 | $5,233,301 | reported | |
| FY 2019 | 2019-12-31 | $3,465,055 | reported | |
| FY 2018 | 2018-12-31 | $1,951,351 revised | reported | |
| FY 2017 | 2017-12-31 | $1,274,499 | reported | |
| FY 2016 | 2016-12-31 | $1,010,663 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported |
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
FY2025 figures · derived
Decoy Therapeutics Inc. is the 517th largest of the 565 covered companies the SEC files under this code, by market cap. SIC 2834
Latest filing Sep 23, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2020 | $0.00 | — | $0.00 | — | 44.73M sh | +227.3% | — |
| FY2019 | $133.59K | $0.00 | $133.59K | — | 13.67M sh | −24.4% | — |
| FY2018 | $0.00 | $615.01K | $615.01K | — | 18.07M sh | +0.5% |
| 14.7% |